Selected article for: "disease prevent and immune response"
Author: Pinheiro, Marcelo Maia; Fabbri, Andrea; Infante, Marco
Title: Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i)
  • Cord-id: m2o4lm4o
  • Document date: 2021_4_28
    • ID: m2o4lm4o
    Snippet: A dysregulated immune response characterized by the hyperproduction of several pro-inflammatory cytokines (a.k.a. ‘cytokine storm’) plays a central role in the pathophysiology of severe coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this Perspective article we discuss the evidence for synergistic anti-inflammatory and immunomodulatory properties exerted by vitamin D and dipeptidyl peptidase-4 (DPP-4) inhibitors, the latter b
    Document: A dysregulated immune response characterized by the hyperproduction of several pro-inflammatory cytokines (a.k.a. ‘cytokine storm’) plays a central role in the pathophysiology of severe coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this Perspective article we discuss the evidence for synergistic anti-inflammatory and immunomodulatory properties exerted by vitamin D and dipeptidyl peptidase-4 (DPP-4) inhibitors, the latter being a class of antihyperglycemic agents used for the treatment of Type 2 diabetes, which have also been reported as immunomodulators. Then, we provide the rationale for investigation of vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i) as an immunomodulation strategy to ratchet down the virulence of SARS-CoV-2, prevent disease progression and modulate the cytokine storm in COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute coronary syndrome and adaptive innate: 1
    • acute coronary syndrome and adaptive innate immunity: 1
    • acute coronary syndrome and additional risk: 1
    • acute host versus graft disease and adaptive immune response: 1
    • acute host versus graft disease and adaptive innate: 1, 2
    • acute host versus graft disease and adaptive innate immunity: 1
    • acute host versus graft disease and additional risk: 1
    • acute illness and adaptive immune response: 1
    • acute illness and adaptive innate: 1, 2, 3, 4, 5, 6, 7
    • acute illness and adaptive innate immunity: 1, 2, 3
    • acute illness and additional benefit: 1, 2
    • acute respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and adaptive innate immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory distress syndrome and additional benefit: 1, 2, 3
    • acute respiratory distress syndrome and additional risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory distress syndrome and adipose tissue dysfunction: 1, 2
    • acute respiratory distress syndrome lead and adaptive innate: 1
    • adaptive innate and additional risk: 1